INDIGO Aspiration System
Penumbra Inc. · Decision date Oct 15, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for the INDIGO® Aspiration System, submitted by Penumbra, Inc. of Alameda, California, under 510(k) number K262904. The decision date is 10/15/2026, with the application received 08/18/2026. The device falls under regulation 870.5150, classification name Peripheral Mechanical Thrombectomy With Aspiration, product code QEW, in the Cardiovascular specialty and review panel. SESE denotes 510(k) clearance, not premarket approval.
The record identifies the application as a Traditional 510(k) and lists clinical trial NCT05003843. It states the submission was not reviewed by a third party, is not a combination product, and has no authorized Predetermined Change Control Plan. The page does not describe the specific device components, modifications or performance data supporting the equivalence finding, so the scope of what was cleared remains unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 15, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262904
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Penumbra Inc.
- Product code
- QEW
- Decision code
- SESE
- Decision date
- Oct 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Peripheral Mechanical Thrombectomy With Aspiration.
- Applicant
- Penumbra Inc.
- Product code
- QEW
- FDA device class
- 2
FDA decision timeline
K262904 received
Application receipt date recorded by FDA.
K262904 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QEW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Triever Duo CatheterK253419 | Inari Medical, Inc. | 510(k) clearance | Sep 18, 2026 | FDA |
| Endovascular Engineering | 510(k) clearance | Sep 3, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Penumbra Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Alameda, CA
Sources and methodology
- Original FDA record: K262904
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
